Authors: Latchman, Y Wood, CR Chernova, T Chaudhary, D Borde, M Chernova, I Iwai, Y Long, AJ Brown, JA Nunes, R Greenfield, EA Bourque, K Boussiotis, VA Carter, LL Carreno, BM Malenkovich, N Nishimura, H Okazaki, T Honjo, T Sharpe, AH Freeman, GJ

Citation: Y. Latchman et al., PD-L2 is a second ligand for PD-I and inhibits T cell activation, NAT IMMUNOL, 2(3), 2001, pp. 261-268

Authors: Carreno, BM Bennett, F Chau, TA Ling, V Luxenberg, D Jussif, J Baroja, ML Madrenas, J

Citation: Bm. Carreno et al., CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression, J IMMUNOL, 165(3), 2000, pp. 1352-1356

Authors: Broeren, CPM Gray, GS Carreno, BM June, CH

Citation: Cpm. Broeren et al., Costimulation light: Activation of CD4(+) T cells with CD80 or CD86 ratherthan anti-CD28 leads to a Th2 cytokine profile, J IMMUNOL, 165(12), 2000, pp. 6908-6914

Authors: Baroja, ML Luxenberg, D Chau, T Ling, V Strathdee, CA Carreno, BM Madrenas, J

Citation: Ml. Baroja et al., The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation, J IMMUNOL, 164(1), 2000, pp. 49-55

Authors: Freeman, GJ Long, AJ Iwai, Y Bourque, K Chernova, T Nishimura, H Fitz, LJ Malenkovich, N Okazaki, T Byrne, MC Horton, HF Fouser, L Carter, L Ling, V Bowman, MR Carreno, BM Collins, M Wood, CR Honjo, T

Citation: Gj. Freeman et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation, J EXP MED, 192(7), 2000, pp. 1027-1034